• Profile
Close

Cost–utility analysis of minimally invasive surgery for lung cancer: A randomized controlled trial

European Journal of Cardio-Thoracic Surgery Mar 09, 2019

Bendixen M, et al. - In order to investigate the cost-effectiveness of video-assisted thoracic surgery (VATS), researchers designed this study as a cost-utility analysis of the first 12 months following surgery. They performed this study together with a clinical randomized controlled trial of VATS vs thoracotomy for lobectomy of stage 1 lung cancer during a 6-year period (2008–2014). They randomized 103 VATS patients and 103 thoracotomy patients. Mean costs per patient operated by VATS were 103,108 Danish Kroner (Dkr) (€13 818) and by thoracotomy were 134,945 Dkr (€18 085). This suggests the costs for VATS 31,837 Dkr (€4267) lower than thoracotomy. Findings thus support that in stage 1 lung cancer, VATS is a cost-effective alternative to thoracotomy following lobectomy. Significantly better economical outcomes as measured by quality-adjusted life years and lower overall costs for VATS were evident.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay